论文部分内容阅读
目的分析抗病毒药物治疗小儿手足口病的安全性及可行性。方法将我院收治的80例小儿手足口病患儿随机分为两组,对照组采用常规治疗方法,观察组在常规治疗基础上加用利巴韦林抗病毒治疗,观察两组患儿治疗的效果及安全性。结果观察组治疗总有效率为95.0%,对照组总有效率为60.0%;观察组患儿无不良反应发生,对照组有3例患儿发生不良反应,观察组在退热、疱疹消退及口腔溃疡愈合时间和平均留观时间方面均显著短于对照组,两组治疗效果、不良反应及各项指标比较差异有统计学意义(P<0.05)。结论抗病毒药物治疗小儿手足口病效果显著,愈合时间短,且无明显毒副作用,安全性较高,是临床治疗手足口病的首选药物,值得临床推广使用。
Objective To analyze the safety and feasibility of antiviral drugs for treating hand-foot-mouth disease in children. Methods Eighty children with HFMD in our hospital were randomly divided into two groups. The control group was treated with routine treatment. The observation group was treated with ribavirin antiviral therapy on the basis of routine treatment. The treatment of two groups of children The effect and safety. Results The total effective rate was 95.0% in the observation group and 60.0% in the control group. No adverse reaction occurred in the observation group, 3 patients in the control group had adverse reactions, and in the observation group there was a decrease in fever, herpes subsidence and oral cavity Ulcer healing time and average viewing time were significantly shorter than the control group, the two groups of treatment, adverse reactions and the indicators were significantly different (P <0.05). Conclusion Antiviral drugs for the treatment of children with hand-foot-mouth disease have significant effects, short healing time, no obvious side effects and high safety. It is the first choice of clinical treatment of hand-foot-mouth disease and is worthy of clinical promotion.